October 18, 2010 - A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with an artificial heart while waiting for a matching donor heart. The patient was implanted with the SynCardia temporary Total Artificial Heart.

October 18, 2010 – Toronto General Hospital is the first Canadian medical center to implant a left-ventricular assist system (LVAS) as part of a study for patients awaiting a heart transplant. The Peter Munk Cardiac Centre used the DuraHeart LVAS, by Terumo Heart, as part of the SUSTAIN BTT study.


St. Jude Medical Inc. said it plans to acquire AGA Medical Holdings Inc. for about $1.3 billion. The purchase will expand St. Jude’s cardiac device offerings with a portfolio of transcatheter structural heart occluders.

October 15, 2010 – The U.S. Food and Drug Administration (FDA) has approved an abbreviated new drug application (ANDA) for a generic equivalent to Novartis’ Lotrel capsules.

October 15, 2010 – Medtronic has entered into a $268 million settlement relating to its Sprint Fidelis family of defibrillation leads.


October 15, 2010 – An investigational trial of Medtronic’s CoreValve transcatheter aortic valve has been approved by the U.S. Food and Drug Administration (FDA) today. The investigational device exemption (IDE) pivotal clinical trial will enroll more than 1,200 patients at 40 U.S. clinical sites.

October 14, 2010 – An injectable magnetic resonance angiography (MRA) blood pool imaging agent has been released in Canada. Ablavar, which is made by Lantheus Medical Imaging and previously marketed as Vasovist, is indicated for contrast-enhanced MRA for visualization of abdominal or limb vessels in patients with suspected or known vascular disease.

October 14, 2010 – A new round of equity financing will help launch the LipiScan IVUS Coronary Imaging System in the United States. InfraReDx raised $21 million to launch the first system to combine intravascular ultrasound (IVUS) with the company’s near infrared (NIR) spectroscopy.

October 14, 2010 – A bifurcation stent maker has closed $17 million in round D financing to help it expand worldwide, pursue research and development and seek out regulatory approvals in the United States, Japan and China. TriReme Medical announced the funding, which was led by Bio*One Capital.

October 14, 2010 – A new echocardiography management program has been launched with Blue Cross and Blue Shield of Vermont (BCBCVT). American Imaging Management (AIM) will partner with BCBSVT to support more consistent use of those services.

AMI has provided diagnostic imaging clinical review services for Vermont health plans since 2008.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now